The cannabis compound cannabigerol (CBG) showed “broad anti-inflammatory effects” in a new study published by the International Journal of Molecular Sciences.
Conducted by researchers at the University Hospital Duesseldorf and the University of Regensburg, both in Germany, the full text of the study can be found by clicking here.
“Since its medical legalization, cannabis preparations containing the major phytocannabinoids (cannabidiol (CBD) and δ9-tetrahydrocannabinol (THC)) have been used by patients with rheumatoid arthritis (RA) to alleviate pain and inflammation”, states the study’s abstract. “However, minor cannabinoids such as cannabigerol (CBG) also demonstrated anti-inflammatory properties, but due to the lack of studies, they are not widely used.”
Continue reading